Scarica l'app Stockscreener
0.3745
4.80%
-0.0189
Dopo l'orario di chiusura:
.37
-0.0045
-1.20%
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics Approves Reverse Stock Split Proposal - TipRanks
Co-Diagnostics (CODX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - sharewise.com
Operating cash flow per share of Co-Diagnostics, Inc. – HAN:C97 - TradingView
Profit Review: Is Co Diagnostics Inc. stock attractive for retirement portfoliosTrade Exit Report & Verified Momentum Stock Alerts - BỘ NỘI VỤ
Is Co Diagnostics Inc. a good long term investmentContrarian Investment Ideas & Build Wealth Brick by Brick With Us - earlytimes.in
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Maxim Group initiates coverage on Co-Diagnostics stock with Buy rating - Investing.com Canada
Maxim Group Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics (CODX) Initiated with 'Buy' Rating by Maxim Group - GuruFocus
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
CFO Brown Surrenders 40,723 Of Co-Diagnostics Inc [CODX] - TradingView
Chmn Egan Surrenders 49,575 Of Co-Diagnostics Inc [CODX] - TradingView
Pres Abbott Surrenders 17,200 Of Co-Diagnostics Inc [CODX] - TradingView
HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX - GuruFocus
Can Co Diagnostics Inc. stock hit analyst price targets2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Will Co Diagnostics Inc. stock attract ESG investorsEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com
Would You Still Hold Co-Diagnostics Stock If It Fell Another 30%? - Trefis
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption - GuruFocus
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - The Herald Journal
Developing predictive dashboards with Co Diagnostics Inc. dataDollar Strength & Fast Moving Stock Trade Plans - newser.com
Chart overlay techniques for tracking Co Diagnostics Inc.Earnings Recap Report & Daily Profit Maximizing Tips - newser.com
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com
Predicting Co Diagnostics Inc. trend using moving averagesWeekly Loss Report & Safe Capital Growth Tips - newser.com
Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
MSN Money - MSN
What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
Co-Diagnostics Inc. (CODX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dxtm PCR Platform to Support Submission to the U.S. FDA - Lelezard
Co-Diagnostics Initiates Clinical Evaluations for Upper Respirat - GuruFocus
Co-Diagnostics initiates clinical evaluations for upper respiratory multiplex point-of-care test on Co-Dx(TM) PCR platform to support submission to the U.S. FDA - MarketScreener
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - PR Newswire
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA – Company AnnouncementFT.com - Financial Times
Sentiment analysis tools applied to Co Diagnostics Inc.July 2025 Volume & Community Consensus Picks - newser.com
What recovery options are there for Co Diagnostics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
3.78%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):